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CC BY-NC-ND license (http://creativeBackground/Purpose: Quality of life (QoL) is found to be lower in heroin addicts; however, few
studies examine detailed QoL performance and related factors in heroin patients attending a
methadone maintenance treatment program (MMTP). The study thus aimed to explore QoL and
its determinants for publicly-funded and self-paid patients attending an MMTP.
Methods: Participants were recruited in Jianan Psychiatric Center, Tainan, Taiwan, during
their first clinic visit for the MMTP. Age-, sex-, education-, and municipality-matched referents
were collected from the 2001 Taiwan National Health Interview Survey database. The partic-
ipants had a mean age of 38.29 years [standard deviation (SD) Z 7.65 years] for publicly-
funded (n Z 129) and 37.97 years (SD Z 7.16 years) for self-paid (n Z 105) MMTP patients.
Matched referents (n Z 217) were 37.74 years (SD Z 7.44 years). All participants were
measured with the brief version of the World Health Organization’s Quality of Lifeeclare that there are no conflicts of interests, and that the agency that funded this research was not
lysis, data interpretation, or writing of the report.
of Public Health, College of Medicine, National Cheng Kung University, No. 1, University Rd., East
com (J.-D. Wang).
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an Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the
commons.org/licenses/by-nc-nd/4.0/).
QoL and its determinants for heroin addicts 715(WHOQOL-BREF) assessment. MMTP patients additionally went through tests for the hepatitis B
virus, hepatitis C virus, and human immunodeficiency virus (HIV).
Results: Both publicly-funded and self-paid MMTP patients had lower QoL scores than their
matched counterparts in the physical and psychological domains (p < 0.05) after control for
confounding by age, sex, education, and municipality. Detailed individual item analyses
showed that publicly-funded MMTP patients had lower scores for almost all items related to
the physical, psychological, and social domains as compared to the referents because of HIV
infection (p < 0.05).
Conclusion: To improve the QoL of heroin users coming for MMTP, we recommend that clini-
cians pay attention to the comorbidity of HIV infection and individual items/facets.
Copyright ª 2015, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).QoL, based on multidimensional underlying conceptsIntroduction
Habitual opioid use has been studied in many countries,1e3
and the findings indicate that dependent opioid users,
including heroin users, continue to use opioids despite their
substantially impaired health. Moreover, many re-
searchers4,5 report that even dependent heroin users who
have sought treatment may continuously use heroin for
decades. Degenhardt et al4 performed a meta-analysis of
58 prospective studies on mortality rates for opioid users,
and found that the crude mortality rate was 2.09 per 100
person-years. In addition, opioid users who are out of
treatment have a higher mortality risk4 and are more
depressed6 than those who are in treatment. A number of
studies have thus examined the importance and effects of
methadone maintenance treatment (MMT), a primary
treatment option for heroin users.7e10
MMT, which provides patients with a daily dosage of
methadone over a long, continuous period, has been
documented to inhibit illicit opiate abuse, human immu-
nodeficiency virus (HIV) risk behavior, criminality, and
mortality.11e13 However, the cost directly related to such
programs (MMTPs) is not covered by the National Health
Insurance (NHI) system in Taiwan, even though this program
covers as much as 99% of the population and includes a
broad coverage of services (e.g., outpatient service, inpa-
tient care, traditional Chinese medicine, dental care,
childbirth, occupational therapy, and physical ther-
apy).14,15 However, because of the rapid spread and high
prevalence of HIV among drug users,16,17 the Taiwan Center
for Disease Control (CDC) has permitted MMTP since 2006 to
control the spread of this disease.18 Moreover, two kinds of
MMTPs (publicly-funded and self-paid) are administered,
with publicly-funded MMTP being free for patients for up to
1 year, while the fee for the self-paid MMTP is about US$100
per month for each patient. Patients who receive publicly-
funded MMTP are required to meet one of the following
criteria: (1) being HIV seropositive; (2) applying for de-
ferred prosecution; or (3) having been incarcerated
because of violating the Drug Control Act. Because of these
criteria, we suspect that the health conditions of such pa-
tients, including the quality of life (QoL), would be
different compared to those seeking self-paid MMTP, and
thus the current study examines this issue.
Due to the health burden of heroin users, in recent years
there has been increasing interest in measuring their QoL.(physical, psychological, social, and environment), provides
clinicians with a holistic view of an individual’s health
condition,19,20 and has been suggested as an important tool
for evaluating drug programs.21 Obtaining a better under-
standing of QoL among heroin users or those receiving
MMTP is thus crucial, with studies finding that such in-
dividuals tend to have impaired QoL, which may be due to
their comorbid infectious diseases, such as hepatitis B virus
(HBV), hepatitis C virus (HCV), and HIV.22e24 For example,
Astals et al22 applied the Short Form-12 to compare QoL
between heroin users and the European general population,
and found that the former group had significantly lower
scores for both the physical and psychological components
of the instrument compared to the general population.
Other researchers25,26 have used the World Health Organi-
zation’s Quality of Life, Brief Version (WHOQOL-BREF) to
examine the QoL of heroin users. Lin et al25 and Yen et al26
compared scores on four domains of the WHOQOL-BREF
between heroin users and healthy controls, and while
both found significant differences for the Physical, Psy-
chological, and Social domains, there was no consistent
finding for the Environment domain.
Although many studies have explored the QoL of heroin
users,22,23,25,26 few have analyzed changes in their scores
and determinants of individual items. There is thus still a
need to understand which facets/items should be paid
more attention to improve the QoL of such patients, and
provide guidance to the clinicians and stakeholders who
take care of them. As such, the purposes of this study were:
(1) to examine the QoL differences between heroin users
coming for MMTPs and their matched referents after
stratification according to whether they were publicly-
funded or self-paid; and (2) to determine the QoL domain
and item scores and their determinants in order to be able
to suggest possible improvements in the care of these
patients.Methods
Participants
The study was approved by the Hospital Ethics Committee of
the Jianan Psychiatric Center, Tainan, Taiwan (Institutional
Review Board number: JMH9601) before commencement.
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qualified psychiatrists from the Jianan Psychiatric Center,
based on the Diagnostic and Statistical Manual of Mental
Disorders, 4th edition (DSM-IV),27 and who were willing to
join the MMTP were invited to participate from March 2006
to July 2008. All participants were required to meet the
following criteria to be recruited for this study: (1) to be
older than 20 years, (2) to have sufficient mental compe-
tence to answer questionnaires, and (3) to be a first time
participant in an MMTP. After signing an informed consent
form, each participant completed a demographic sheet and
the WHOQOL-BREF questionnaire; all participants also un-
derwent HBV, HCV, and HIV tests.
Participants were classified as publicly-funded MMTP
(nZ 129) if they met one of the following criteria: (1) being
HIV seropositive; (2) applying for deferred prosecution; or
(3) having been incarcerated because of violating the Drug
Control Act. Otherwise, the participant was classified as a
self-paid MMTP (n Z 105) participant.
A matched reference group was randomly sampled from
the 2001 National Health Interview Survey (NHIS) database
constructed by the National Health Research Institutes and
the Bureau of Health Promotion, Department of Health,
Taiwan. They were matched with the MMTP participants
based on age ( 5 years), sex, years in education (< 6
years, 7e12 years, and  13 years), and municipality. The
purpose of the 2001 NHIS is to provide nationwide health-
related estimates, including health conditions, health
behavior, and usage of medical resources, for the popula-
tion of Taiwan. Using multi-stage sampling proportioned to
household population size, a total of 27,160 eligible people
living in 7357 households were identified, and thus the
sample was representative of the Taiwanese population
with regard to age, sex, and the urbanization index.28
Subsequently, the 2001 NHIS collected 25,464 people
living in 6271 households (response rate: 93.8% by person
and 91.4% by household) from August 2001 to January
2002.29 In addition, 13,048 people aged from 20 years to 89
years filled out the WHOQOL-BREF, which was one of the
tools used to measure various health-related factors such as
healthy behaviors.30
The healthy control participants were matched using a
simple random method with the following steps: (1) each
healthy control was assigned a random number; (2) all the
controls were grouped according to age, sex, municipality,
and years in education; (3) the controls were put into
sequence in their groups based on the random number that
had been assigned to them; (4) the healthy controls were
matched to the heroin-dependent patients using a 1:1
ratio; (5) all selected controls were moved out of the pool;
(6) 1 year was added or subtracted to the age of the con-
trols when no more controls can be matched with the pa-
tients; and (7) Step 6 was carried out repeatedly, for a total
addition or subtraction of up to 5 years. We decided to use
a 1:1 ratio for selecting healthy controls based on the
following power calculations: using a small effect size
(Cohen’s dZ 0.2) on a two-sided paired t test with an alpha
error of 0.05 and power of 0.8; the suggested total sample
size, as obtained by G*Power 3.1.5,31 was 199. Each group
thus needed 100 individuals, giving a total sample size of
200 for the comparison. Because our heroin-dependent
sample was 234 (publicly-funded, 129 and self-paid, 105),the 1:1 ratio would be sufficient for each comparison of
heroin users and healthy controls. However, we finally
matched only 217 healthy controls (113 matched with
publicly-funded and 104 with self-paid) for the following
reason: our heroin-dependent sample was generally young
people with low educational levels. In fact, > 95% of them
have been educated for < 12 years (Table 1), in contrast to
the majority of young people in Taiwan, who have been to
junior college or higher. Nevertheless, we obtained > 100
pairs of matched healthy controls and heroin users for both
publicly-funded and self-paid MMTP, thus giving sufficient
power for data analyses.
WHOQOL-BREF
The WHOQOL-BREF Taiwan version is a generic QoL ques-
tionnaire that contains two general items (viz., “overall
QoL” and “general health”) and 26 items within four do-
mains (viz., Physical: 7 items, Psychological: 6 items, So-
cial: 4 items, and Environment: 9 items). The WHOQOL-
BREF Taiwan version was developed in 1999 under the WHO
guidelines,32 for which strong psychometric properties have
been found, including reliability (internal consistency and
testeretest reliability) and validity (content validity,
criterion-related validity, known-group validity, and
construct validity).32,33 In addition, satisfactory psycho-
metric properties were also established in a sample with
psychiatric disorders,19 as well as in one with heroin
addiction.34 Each item scored from 1 (representing the
worst condition) to 5 (representing the best), except for
three items (“Pain and discomfort” and “Medication” in the
Physical domain, and “Negative feelings” in the Psycho-
logical domain) that were reversely coded. In addition,
domain scores were calculated according to a 4e20 scale,
where a higher score represented better QoL.
In addition to the domain scores, we also applied the
item scores for in-depth analyses, and this was done for the
following reasons. First, the item score could provide us
with more detailed information than the total score.35 For
example, if someone has a low score in the Physical
domain, clinicians may have difficulties defining which
physical problems they suffer from. By contrast, if someone
has a low score in the item of activities of daily living, then
clinicians would be able to focus on this major functional
problem. Second, the item properties of the WHOQOL-BREF
have been found to be satisfactory.34
Data analysis
All data were analyzed using SPSS software, version 15.0
(SPSS Inc., Chicago, IL, USA). Descriptive analyses were
applied to show participant characteristics for each group
(publicly-funded MMTP, self-paid MMTP, and matched
referents). Differences in the WHOQOL-BREF domain
scores between publicly-funded MMTP and matched ref-
erents, and those between self-paid MMTP and matched
referents, were analyzed using paired t tests. In addition,
Cohen’s d (aka effect size) was used to detect the
magnitude of the differences, and values of 0.2, 0.5, and
0.8 indicated small, moderate, and large effects, respec-
tively. The Cohen’s d was calculated as: (WHOQOL-BREF
Table 1 Demographics and WHOQOL-BREF scores for patients coming for a methadone maintenance treatment program
(MMTP) and matched referents from the general Taiwanese population.
Publicly-funded
(n Z 129)
Matched referentsa
(n Z 113)
Cohen’s d Self-paid
(n Z 105)
Matched referentsa
(n Z 104)
Cohen’s d
Age (y) 38.29  7.65 37.53  7.75 37.97  7.16 37.97  7.13
Sex
Female 11 (8.5) 11 (9.7) 13 (12.4) 13 (12.5)
Male 118 (91.5) 102 (90.3) 92 (87.6) 91 (87.5)
Educational years
< 6 y 4 (3.1) 4 (3.5) 1 (0.9) 1 (1.0)
7e12 y 119 (92.2) 103 (91.2) 103 (98.2) 102 (98.0)
 13 y 6 (4.7) 6 (5.3) 1 (0.9) 1 (1.0)
Living statusb
With others 118 (91.5) 98 (96.1)
Alone 11 (8.5) 4 (3.9)
Age of first heroin
use (y)
25.59  5.89 26.92  6.80
Employment statusb
Fixed 68 (53.1) 56 (53.3)
Nonfixed 60 (46.9) 49 (46.7)
HIV carrier
Seronegative 84 (65.1) 105 (100.0)
Seropositive 45 (34.9) 0 (0.0)
HBV carrier
Seronegative 106 (82.2) 89 (84.8)
Seropositive 23 (17.8) 16 (15.2)
HCV carrier
Seronegative 4 (3.1) 9 (9.4)
Seropositive 125 (96.9) 96 (90.6)
WHOQOL-BREF
Physical 11.93  1.86 15.01  1.93 1.12*** 12.53  1.90 15.44  2.15 1.07***
Psychological 12.01  2.66 13.51  2.34 0.41*** 12.88  2.07 13.58  2.44 0.24*
Social 12.73  3.13 13.95  1.98 0.31** 13.50  2.76 14.03  2.34 0.15
Environment 12.47  2.80 12.86  1.88 0.12 13.48  2.24 12.88  2.18 0.20*
Data are presented as n (%) or mean  SD.
* p < 0.05.
** p < 0.01.
*** p < 0.001.
Cohen’s dZ mean difference divided by pooled SD; HBVZ hepatitis B virus; HCVZ hepatitis C virus; HIVZ human immunodeficiency
virus; SD Z standard deviation; WHOQOL-BREF Z Taiwanese brief version of the World Health Organization’s quality of life.
a Matched referents were paired with MMTP patients according to age ( 5 years), sex, years of education, and municipality.
b With missing values.
QoL and its determinants for heroin addicts 717domain scores for the publicly-funded MMTP or self-paid
MMTP group minus WHOQOL-BREF domain scores for
matched referents) divided by the pooled standard devi-
ation (SD).35,36 A negative d value indicated that the MMTP
groups had a QoL lower than those of their matched
counterparts, and a positive d value indicated that the
MMTP groups rated their QoL as being higher than their
matched counterparts did.
Regression models in univariate and multivariate levels
were constructed to determine the impacts of MMTP. Spe-
cifically, the regression models constructed healthy con-
trols as the reference group to compare their QoL scores
with publicly-funded and self-paid MMTP patients. More-
over, additional hierarchical multiple linear regression
models were used to determine the effect of publicly-funded MMTP and self-paid MMTP on QoL scores (including
the WHOQOL-BREF domain scores and item scores) with
adjustment for demographic and/or clinical characteristics
(Model 0: without any adjustment; Model 1: age, sex,
educational years, living status, and fixed employment;
Model 2: age, sex, educational years, living status, fixed
employment, HIV-positive, HBV-positive, and HCV-positive
infections). However, because we did two sets of regression
models (i.e., 1 set of healthy controls vs. MMTP patients
and another set of publicly-funded vs. self-paid MMTP pa-
tients), we adopted Bonferroni adjustment to control the
second set of regression models, with p Z 0.025 being
significant. In addition, sensitivity analyses were performed
for males only in all the above analyses, including paired t
tests, Cohen’s d, and regression models.
718 C.-Y. Lin et al.Results
In total, 234 patients coming for an MMTP together with 217
age-, sex-, municipal- and education-matched healthy
referents were successfully recruited, and their de-
mographics were comparable, as summarized in Table 1. In
addition, few MMTP participants lived alone (8.5% in
publicly-funded MMTP and 3.9% in self-paid MMTP), and
slightly more than half of them had fixed employment
among both the publicly-funded and self-paid MMTPs. HIV
carriers were mainly in the publicly-funded MMTP group
(65.1%), while the self-paid MMTP group had no HIV car-
riers. Less than one fifth of the MMTP participants were HBV
carriers, and > 90% were infected with HCV. Moreover, the
mean ages of first heroin use were 25.59  5.89 years for
those in the publicly-funded MMTP group, and 26.92  6.80
years for those in the self-paid MMTP group (Table 1).
Publicly-funded MMTP participants had significantly
lower scores in the physical, psychological and social do-
mains as compared with their matched referents, of which
the magnitude of difference for the Physical domain was
found to be the largest (d Z 1.12), followed by the Psy-
chological (dZ 0.41), and Social (dZ 0.31) domains, as
summarized in Table 2. By contrast, the self-paid MMTP
participants showed significantly lower scores in the Physical
and Psychological domains, but the scores in the Environ-
ment domain were higher in comparison to those of their
matched referents. In addition, the magnitude of difference
for scores was large for the Physical domain (dZ1.07) and
small for the Psychological domain (Table 1).
After adjustment for demographic characteristics (age,
sex, and years in education), publicly-funded MMTP par-
ticipants showed significantly lower scores for all items in
the Physical, Psychological, and Social domains, and for
four of nine items in the Environment domain, in compar-
ison with the matched referents, as summarized in Table 3.
By contrast, significantly lower scores were found for five of
seven items in the Physical domain, one of six items in the
Psychological domain, and one of four items in the Social
domain among the self-paid participants as compared with
their matched referents. The self-paid participants also
showed significantly higher scores for three out of nine
items in the Environment domain (Table 2).
We constructed linear models to compare QoL scores be-
tween publicly-funded and self-paid MMTP participants, with
the results showing that the former had significantly lower
scores in eight out of 26 items, as summarized in Table 3.
However, all these differences disappeared after incorpo-
rating clinical data and controlling for confounding. In other
words, differences in the payment scheme were not associ-
ated with any significant QoL score difference in Model 2.
Instead, the significant differences for six out of eight items
wereexplainedbyHIV infection (Model 2), forwhich therewas
no significant difference in any item or domain score in the
Physical domain. Similar trends can be also found in only male
heroin users, based on our sensitivities analyses (Appendix 1).
Discussion
In general, our results indicating that heroin users tend to
have a poorer QoL than healthy controls are corroboratedby previous reports,22,37 including studies conducted in
Taiwan.25,26 The two Taiwanese studies25,26 documented
lower scores in the Physical, Psychological, and Social do-
mains in MMTP patients compared with those for healthy
referents after controlling for age, sex, and education.
Because some studies38,39 have reported that people living
in rural areas tend to exhibit lower QoL scores as compared
with those living in urban areas, we controlled for munici-
pality and corroborated the findings of poorer scores in
patients coming for MMTPs (Table 1). Moreover, we exam-
ined the scores for individual items to obtain more detailed
results, and derived some new information that should be
of interest to stakeholders (Table 2). Because publicly-
funded MMTP patients had generally poorer scores in all
items and domains in comparison with those that were self-
paid, we controlled clinical factors for potential con-
founding and found that HIV infection explains the major
differences between these two groups (Table 3). However,
because we simultaneously controlled HIV, HBV, and HCV
infections, their effects were adjusted. The results showed
that HIV infection had a significant effect on many item
scores, while those of HBV and HCV infections did not. In
addition, we used another set of regression models that
omitted HBV and HCV infections (Appendix 2), and the re-
sults were almost identical to those for Model 2 in Table 3.
Therefore, we are confident in our results of the full model
(i.e., Model 2) on Table 3.
According to the current government regulations in
Taiwan, enacted to control the spread of HIV and heroin
abuse, a patient is only eligible for publicly-funded MMTP if
he/she is either HIV seropositive or has a criminal record
(e.g., for a violation of the Drug Control Act). These pa-
tients may have more difficulties related to social interac-
tion in the community than self-paid MMTP patients,
because there is a stigma related to carrying HIV40 and
being a criminal,41 thus they may not live in a friendly
environment. The results of our multiple linear regressions
show that the group effect (publicly-funded vs. self-paid)
diminished after we included HIV infection in the model
(Table 3), and that the effects of most items/facets shifted
toward individuals being HIV-positive. We thus tentatively
concluded that the QoL differences between the two
groups were at least partially due to the impact of being
HIV-positive. This result provides clinicians with an impor-
tant direction for treating MMTP patients, as HIV should be
simultaneously diagnosed and treated during such pro-
grams. Because we did not have access to the criminal re-
cords of our participants, we were unable to explore the
effects of these on QoL for the patients undergoing MMTP.
However, we could see that the score differences for self-
esteem (Psychological domain), personal relationship, so-
cial support, being respected (Social domain), health ser-
vice, and transportation (Environment domain) were not
explained by HIV infection, and thus they might be attrib-
uted to the criminal records of the MMTP patients. How-
ever, further research is needed to examine this
hypothesis.
Our finding of impaired QoL for the heroin users exam-
ined in this study generally agreed with previous
studies.22,25,26 However, some differences were found
when we carefully compared our results with those of two
other studies25,26 using the same instrument, i.e., the
Table 2 Regression coefficients of model construction for publicly-funded and self-paid methadone maintenance treatment program (MMTP) patients versus matched
referentsa on the WHOQOL-BREF.
Domain
Item #
Item description Univariateb Multivariatec
Publicly-funded Self-paid Publicly-funded Self-paid
B(SE) p B (SE) p B(SE) p B(SE) p
Physical 3.26 (0.22) < 0.001* 2.73 (0.24) < 0.001* 3.27 (0.22) <0.001* 2.72 (0.24) <0.001*
Q3 Pain & discomfort 1.52 (0.11) < 0.001* 1.49 (0.12) < 0.001* 1.52 (0.11) <0.001* 1.48 (0.12) <0.001*
Q4 Medication 2.06 (0.11) < 0.001* 2.23 (0.11) < 0.001* 2.04 (0.11) <0.001* 2.25 (0.11) <0.001*
Q10 Energy & fatigue 0.39 (0.09) < 0.001* 0.14 (0.10) 0.14 0.40 (0.09) <0.001* 0.14 (0.10) 0.16
Q15 Mobility 0.44 (0.09) < 0.001* 0.25 (0.10) 0.008* 0.44 (0.09) <0.001* 0.25 (0.10) 0.01*
Q16 Sleep & rest 0.62 (0.10) < 0.001* 0.38 (0.11) 0.001* 0.63 (0.10) <0.001* 0.37 (0.11) 0.001*
Q17 Activities of daily living 0.36 (0.08) < 0.001* 0.21 (0.09) 0.02* 0.36 (0.08) <0.001* 0.21 (0.09) 0.02*
Q18 Work capacity 0.35 (0.10) < 0.001* 0.12 (0.10) 0.24 0.35 (0.10) <0.001* 0.13 (0.10) 0.22
Psychological 1.59 (0.27) < 0.001* 0.71 (0.29) 0.014* 1.61 (0.27) <0.001* 0.68 (0.29) 0.019*
Q5 Positive feelings 0.24 (0.11) 0.03* 0.04 (0.12) 0.73 0.25 (0.11) 0.02* 0.06 (0.12) 0.62
Q6 Spirit/religion/beliefs 0.38 (0.12) 0.001* 0.15 (0.13) 0.24 0.40 (0.12) 0.001* 0.13 (0.13) 0.30
Q7 Concentration 0.48 (0.10) < 0.001* 0.01 (0.11) 0.90 0.48 (0.10) <0.001* 0.003 (0.11) 0.98
Q11 Body image 0.24 (0.10) 0.02* 0.02 (0.11) 0.85 0.24 (0.10) 0.02* 0.02 (0.11) 0.86
Q19 Self-esteem 0.45 (0.09) < 0.001* 0.19 (0.10) 0.06 0.45 (0.09) <0.001* 0.19 (0.10) 0.06
Q26 Negative feelings 0.60 (0.10) < 0.001* 0.73 (0.11) < 0.001* 0.60 (0.10) <0.001* 0.73 (0.11) <0.001*
Social 1.37 (0.29) < 0.001* 0.55 (0.31) 0.08 1.37 (0.29) <0.001* 0.54 (0.31) 0.09
Q20 Personal relationship 0.20 (0.08) 0.02* 0.06 (0.09) 0.48 0.20 (0.09) 0.02* 0.06 (0.09) 0.48
Q21 Sexual activity 0.70 (0.10) < 0.001* 0.35 (0.11) 0.001* 0.70 (0.10) <0.001* 0.35 (0.11) 0.001*
Q22 Social support 0.25 (0.09) 0.007* 0.15 (0.10) 0.12 0.25 (0.09) 0.008* 0.15 (0.10) 0.12
Q27 Being respected 0.22 (0.09) 0.016* 0.01 (0.10) 0.92 0.23 (0.09) 0.015* 0.01 (0.10) 0.90
Environment 0.40 (0.26) 0.13 0.56 (0.28) 0.048* 0.42 (0.26) 0.11 0.58 (0.28) 0.04*
Q8 Safety & security 0.23 (0.11) 0.03* 0.10 (0.11) 0.40 0.24 (0.11) 0.025* 0.11 (0.12) 0.35
Q9 Physical environment 0.02 (0.10) 0.87 0.41 (0.11) < 0.001* 0.02 (0.10) 0.88 0.42 (0.11) <0.001*
Q12 Financial resources 0.31 (0.12) 0.007* 0.06 (0.12) 0.64 0.33 (0.12) 0.004* 0.04 (0.12) 0.75
Q13 Information acquisition 0.27 (0.10) 0.007* 0.01 (0.11) 0.97 0.28 (0.10) 0.006* 0.002 (0.11) 0.98
Q14 Leisure activities 0.05 (0.11) 0.65 0.45 (0.11) < 0.001* 0.04 (0.11) 0.70 0.47 (0.11) <0.001*
Q23 Home environment 0.05 (0.09) 0.56 0.07 (0.10) 0.46 0.06 (0.09) 0.52 0.08 (0.10) 0.42
Q24 Health service 0.16 (0.09) 0.08 0.22 (0.10) 0.02* 0.16 (0.09) 0.075 0.21 (0.10) 0.03*
Q25 Transportation 0.17 (0.09) 0.047* 0.02 (0.09) 0.85 0.18 (0.09) 0.046* 0.02 (0.09) 0.82
Q28 Eating 0.08 (0.09) 0.40 0.08 (0.10) 0.43 0.08 (0.10) 0.38 0.08 (0.10) 0.42
* Statistically significant (p < 0.05).
BZ regression coefficient; MMTPZmethadone maintenance treatment program; SEZ standard error; WHOQOL-BREFZ Taiwanese brief version of World Health Organization’s quality of
life.
a Referents were selected from the general population and matched according to age, sex, education, and municipality with MMTP
patients.
b Without any adjustment.
c Adjusted for age, sex, and educational years.
Q
o
L
a
n
d
its
d
e
te
rm
in
a
n
ts
fo
r
h
e
ro
in
a
d
d
icts
719
Table 3 Regression coefficients of model construction for WHOQOL-BREF scores comparing self-paid and publicly-funded methadone maintenance treatment program
(MMTP) patients.
Domain
Item #
Model 0a Model 1b Model 2c
Self-paid vs. publicly-funded Self-paid vs. publicly-funded Self-paid vs. publicly-funded HIV-positive vs. HIV-negative
B (SE) pd B (SE) pd B (SE) pd B (SE) pd
Physical 0.53 (0.25) 0.036 0.64 (0.25) 0.012* 0.50 (0.28) 0.08 0.37 (0.36) 0.30
Q3: Pain & discomfort 0.03 (0.13) 0.83 0.03 (0.14) 0.81 0.06 (0.15) 0.68 0.11 (0.19) 0.55
Q4: Medication 0.18 (0.13) 0.18 0.18 (0.13) 0.19 0.05 (0.15) 0.72 0.29 (0.19) 0.12
Q10: Energy & fatigue 0.25 (0.11) 0.027 0.29 (0.11) 0.012* 0.17 (0.13) 0.18 0.31 (0.16) 0.057
Q15: Mobility 0.19 (0.11) 0.09 0.20 (0.11) 0.07 0.19 (0.13) 0.77 0.03 (0.16) 0.87
Q16: Sleep & rest 0.23 (0.13) 0.08 0.30 (0.13) 0.026 0.21 (0.15) 0.17 0.23 (0.19) 0.21
Q17: Activities of daily living 0.14 (0.10) 0.17 0.17 (0.10) 0.10 0.07 (0.12) 0.55 0.28 (0.15) 0.055
Q18: Work capacity 0.23 (0.12) 0.07 0.27 (0.12) 0.028 0.17 (0.14) 0.21 0.23 (0.17) 0.19
Psychological 0.89 (0.32) 0.006* 0.89 (0.32) 0.006* 0.45 (0.35) 0.20 1.23 (0.44) 0.006*
Q5: Positive feelings 0.28 (0.13) 0.035 0.30 (0.13) 0.025* 0.15 (0.15) 0.32 0.46 (0.18) 0.013*
Q6: Spirit/religion/beliefs 0.23 (0.15) 0.12 0.23 (0.15) 0.15 0.05 (0.16) 0.78 0.52 (0.21) 0.013*
Q7: Think 0.47 (0.13) < 0.001* 0.45 (0.13) 0.001* 0.24 (0.14) 0.09 0.60 (0.18) 0.001*
Q11: Body image 0.22 (0.12) 0.08 0.23 (0.13) 0.07 0.18 (0.14) 0.22 0.16 (0.18) 0.38
Q19: Self-esteem 0.26 (0.12) 0.025* 0.30 (0.12) 0.012* 0.18 (0.13) 0.17 0.32 (0.17) 0.055
Q26: Negative feelings 0.13 (0.13) 0.33 0.17 (0.13) 0.20 0.11 (0.14) 0.45 0.20 (0.18) 0.27
Social 0.82 (0.39) 0.038 0.79 (0.40) 0.051 0.14 (0.44) 0.76 1.93 (0.55) 0.001*
Q20: Personal relationship 0.13 (0.11) 0.21 0.14 (0.11) 0.20 0.07 (0.12) 0.54 0.20 (0.15) 0.20
Q21: Sexual activity 0.34 (0.13) 0.009* 0.33 (0.14) 0.015* 0.10 (0.15) 0.49 0.66 (0.19) 0.001*
Q22: Social support 0.10 (0.12) 0.43 0.07 (0.13) 0.59 0.08 (0.14) 0.58 0.43 (0.18) 0.015*
Q27: Being respected 0.23 (0.12) 0.052 0.24 (0.12) 0.055 0.02 (0.13) 0.87 0.64 (0.17) <0.001*
Environment 0.95 (0.35) 0.006* 0.93 (0.35) 0.001* 0.42 (0.39) 0.27 1.48 (0.49) 0.003*
Q8: Safety and security 0.33 (0.13) 0.014* 0.31 (0.13) 0.02* 0.18 (0.15) 0.22 0.46 (0.19) 0.015*
Q9: Physical environment 0.40 (0.12) 0.001* 0.34 (0.12) 0.006* 0.18 (0.13) 0.17 0.40 (0.17) 0.02*
Q12: Financial resources 0.25 (0.14) 0.07 0.28 (0.14) 0.05 0.12 (0.16) 0.43 0.44 (0.20) 0.027
Q13: Information acquiring 0.27 (0.13) 0.037 0.25 (0.13) 0.048 0.12 (0.14) 0.41 0.43 (0.18) 0.018*
Q14: Leisure activities 0.41 (0.13) 0.002* 0.41 (0.13) 0.003* 0.20 (0.15) 0.18 0.59 (0.18) 0.001*
Q23: Home environment 0.12 (0.11) 0.24 0.09 (0.11) 0.41 0.02 (0.12) 0.89 0.29 (0.15) 0.051
Q24: Health service 0.06 (0.11) 0.61 0.09 (0.12) 0.46 0.02 (0.13) 0.85 0.19 (0.16) 0.25
Q25: Transportation 0.16 (0.11) 0.15 0.18 (0.11) 0.09 0.07 (0.12) 0.73 0.33 (0.15) 0.03
Q28: Eating 0.16 (0.11) 0.16 0.14 (0.11) 0.22 0.07 (0.13) 0.59 0.20 (0.16) 0.22
* Statistically significant (p < 0.025).
BZ regression coefficient; HBVZ hepatitis B virus; HCVZ hepatitis C virus; HIVZ human immunodeficiency virus; MMTPZ methadone maintenance treatment program; SEZ standard
error; WHOQOL-BREF Z Taiwanese brief version of the World Health Organization’s quality of life.
a Without any adjusted variable.
b Age, sex, educational years, living status, and fixed employment were adjusted.
c Age, sex, educational years, living status, fixed employment, HIV-positive, HBV-positive, and HCV-positive infections were adjusted.
d Bonferroni adjustment for multiple comparisons was used, and the significant p value was set at 0.025 because we compared healthy
controls versus MMTP patients (Table 2) and publicly-funded MMTP versus self-paid MMTP patients (Table 3).
720
C
.-Y.
Lin
e
t
a
l.
QoL and its determinants for heroin addicts 721WHOQOL-BREF. Because different scales of the WHOQOL-
BREF were adopted, we first converted all WHOQOL-BREF
domain scores in the two earlier studies25,26 into a 4e20
scale, and calculated the Cohen’s d. We found that Lin
et al25 reported a significant and large difference in Envi-
ronment domain scores between heroin users and healthy
controls, as summarized in Appendix 3. However, this trend
was not found in our results and those of Yen et al26 The
differences among these studies were thus mainly due to
the different WHOQOL-BREF scores among healthy controls
(Lin et al25 14.08  2.08; Yen et al26 12.26  2.58; referents
of our publicly-funded participants, 12.86  1.88; referents
of our self-paid participants, 12.88  2.18), as the
WHOQOL-BREF domain scores were similar for heroin users
in previous studies25,26 and the current one. A potential
explanation for this is that the healthy controls were
recruited from different areas and might have expressed
different subjective feelings about their environments.
Although previous studies22,25,26 reported low QoL
domain scores among heroin users, they did not delineate
the detailed difficulties and suffering related to clinical
care.35 A layer by layer analysis of QoL difficulties from
domain scores to item scores is thus critical. Taking our
results as examples, both publicly-funded MMTP and self-
paid MMTP patients (or we may say HIV-positive and nega-
tive MMTP patients, respectively) were found to have
physical and psychological QoL problems. However, using
item scores we found that publicly-funded MMTP (HIV-
positive) patients had worse scores for all of the items in
the Physical and Psychological domains compared to their
matched counterparts. As for self-paid MMTP (HIV-nega-
tive) patients, they seemed to have no problems related to
“Energy and fatigue” and “Work capacity” in the Physical
domain, and seemed to only have one problem (“Negative
feelings”) in the Psychological domain. Based on the in-
formation obtained from a detailed analysis of individual
item scores, clinicians will be able to address the different
physical and psychological needs of publicly-funded MMTP
(HIV-positive) and self-paid MMTP (HIV-negative) patients.
Another interesting finding from the item-level analyses
was that the self-paid MMTP patients had three item scores
(Q9: Physical environment; Q14: Leisure activities; Q24:
Health service) that were significantly higher than their
counterparts. A possible explanation for this is that the
self-paid MMTP patients may have a higher socioeconomic
status, and thus they were more likely to live in a healthier
physical environment, have enough resources for leisure
activities, and receive adequate health services. An alter-
native explanation would be that they felt better able to
master their environmental conditions, and thus tended to
report high scores for these three items. However, as we
did not have any additional data to corroborate these hy-
potheses, future studies on this issue are needed.
The strength of this study was that it collected repre-
sentative referents and conducted a comprehensive control
of confounding factors for comparison, and thus it is able to
provide clinicians with valuable knowledge related to
managing MMTP patients. However, this study also has the
following limitations. First, the participants were recruited
from patients who were coming for their first clinic visit forMMTP, and thus generalizing our results to those who have
already been receiving MMTP treatment may not be
appropriate. However, the results of this study of fresh
patients could be used as a guide for clinicians in order to
make improvements to various items and domains, as
highlighted by the QoL findings. Second, because all in-
dividuals participated in MMTP, the findings of this study
may not be applicable to heroin users who are receiving no
treatment. Third, because the WHOQOL-BREF is a self-
rated measurement, heroin users with impaired cognitive
abilities may rate their QoL scores inaccurately. However,
the WHOQOL-BREF has been validated using item response
theory in patients who were heroin-dependent,34 and so
any such bias may not be significant. Fourth, the matched
referents were collected in 2001, and the heroin users
coming for MMTP were recruited from 2006 to 2008, and
thus there was a time gap between when the two groups’
data was collected, and this may have impacted the
WHOQOL scores, especially for the Social and Environment
domains. Finally, because the NHIS data did not include
living status and specific chronic viral infections in the
survey, such as HBV, HCV, HIV, and so on, we were unable to
adjust for these factors in the QoL analysis. However, both
HBV and HCV are chronic infections, and patients usually
appear to be healthy unless cirrhosis and/or liver cancer
develops, and before this they may not significantly affect
the patients’ QoL. By contrast, HIV infection, although also
chronic, generally affects patient’s QoL in many aspects,
especially since it is still seen as a stigma in Taiwan.
Therefore, the impairment of QoL among heroin users may
at least be partially attributed to their HIV status, and
possibly also to HBV and HCV infections. Future studies
collecting a sample of controls with the same conditions
would be useful to clarify the magnitudes to which these
infections confounded our results.
In conclusion, heroin users in MMTP, especially those
with HIV infection, suffer from poorer QoL in the Physical,
Psychological, and Social domains as compared with age-,
sex-, education-, and municipality-matched referents.
Further analyses of individual items sheds some light on
possible improvements to treatment practices. HBV and
HCV infection, which currently have effective treatments
that are available, appear to impact QoL less in the case of
MMTP patients. By contrast, HIV infection is a major factor
that should be diagnosed and addressed, while the stigma
of heroin use and HIV infection is another factor that should
be examined in future studies.Acknowledgments
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722 C.-Y. Lin et al.Appendix 1. Sensitivity analyses for males only.Table S1 Demographics and WHOQOL-BREF scores between patients coming for a methadone maintenance treatment pro-
gram (MMTP) and matched referents from the general Taiwanese population.
Publicly-funded
(n Z 118)
Matched referentsa
(n Z 102)
Cohen’s d Self-paid
(n Z 92)
Matched referentsa
(n Z 91)
Cohen’s d
Age (y) 39.04  7.36 38.28  7.54 38.88  7.08 38.87  7.08
Educational years
< 6 y 4 (3.4) 4 (3.9) 1 (1.1) 1 (1.1)
7e12 y 108 (91.5) 92 (90.2) 90 (97.8) 89 (97.8)
 13 y 6 (5.1) 6 (5.9) 1 (1.1) 1 (1.1)
Living statusb
With others 107 (90.7) 85 (95.5)
Alone 11 (9.3) 4 (4.5)
Age of 1st heroin use (y) 25.55  5.86 27.59  6.89
Employment statusb
Fixed 65 (55.6) 53 (57.6)
Nonfixed 52 (44.4) 39 (42.4)
HIV carrier
Seronegative 78 (66.1) 92 (100.0)
Seropositive 40 (33.9) 0 (0.0)
HBV carrier
Seronegative 95 (80.5) 79 (85.9)
Seropositive 23 (19.5) 13 (14.1)
HCV carrier
Seronegative 4 (3.4) 7 (7.6)
Seropositive 114 (96.6) 85 (92.4)
WHOQOL-BREF
Physical 11.97  1.82 15.06  1.93 1.11*** 12.62  1.95 15.38  2.17 0.98***
Psychological 12.03  2.61 13.57  2.32 0.42*** 13.00  2.16 13.58  2.49 0.19
Social 12.60  3.13 13.98  2.01 0.35** 13.60  2.75 14.03  2.39 0.12
Environment 12.52  2.71 12.90  1.82 0.12 13.53  2.31 12.88  2.18 0.21*
Data are presented as n (%) or mean  SD.
* p < 0.05.
** p < 0.01.
*** p < 0.001.
Cohen’s dZ mean difference divided by pooled SD; HBVZ hepatitis B virus; HCVZ hepatitis C virus; HIVZ human immunodeficiency
virus; SD Z standard deviation; WHOQOL-BREF Z Taiwanese brief version of the World Health Organization’s quality of life.
a Matched referents were paired with MMTP patients according to age ( 5 years), sex, years of education, and municipality.
b With missing values.
Table S2 Regression coefficients of model construction for publicly-funded and self-paid methadone maintenance treatment
program (MMTP) patients versus matched referentsa on the WHOQOL-BREF.
Domain
Item #
Item description Univariateb Multivariatec
Publicly-funded Self-paid Publicly-funded Self-paid
B(SE) p B (SE) p B(SE) p B(SE) p
Physical 3.23 (0.23) < 0.001* 2.65 (0.25) < 0.001* 3.23 (0.23) < 0.001* 2.64 (0.25) <0.001*
Q3 Pain & discomfort 1.51 (0.11) < 0.001* 1.49 (0.12) < 0.001* 1.51 (0.11) < 0.001* 1.48 (0.12) <0.001*
Q4 Medication 2.05 (0.11) < 0.001* 2.25 (0.12) < 0.001* 2.03 (0.11) < 0.001* 2.27 (0.12) <0.001*
Q10 Energy & fatigue 0.38 (0.10) < 0.001* 0.12 (0.10) 0.24 0.38 (0.10) < 0.001* 0.12 (0.11) 0.25
Q15 Mobility 0.42 (0.09) < 0.001* 0.22 (0.10) 0.031* 0.42 (0.09) < 0.001* 0.21 (0.10) 0.037*
Q16 Sleep & rest 0.62 (0.11) < 0.001* 0.36 (0.12) 0.002* 0.63 (0.11) < 0.001* 0.36 (0.12) 0.002*
Q17 Activities of daily
living
0.35 (0.09) < 0.001* 0.18 (0.09) 0.06 0.35 (0.09) < 0.001* 0.17 (0.09) 0.07
Q18 Work capacity 0.36 (0.10) < 0.001* 0.06 (0.11) 0.60 0.36 (0.10) < 0.001* 0.06 (0.11) 0.56
Psychological 1.62 (0.28) < 0.001* 0.63 (0.31) 0.043* 1.62 (0.28) < 0.001* 0.60 (0.31) 0.054
Q5 Positive feelings 0.21 (0.11) 0.07 0.05 (0.12) 0.70 0.21 (0.11) 0.06 0.07 (0.12) 0.59
Q6 Spirit/religion/beliefs 0.38 (0.12) 0.003* 0.12 (0.13) 0.36 0.38 (0.12) 0.002* 0.10 (0.13) 0.44
Q7 Concentration 0.47 (0.11) < 0.001* 0.02 (0.12) 0.89 0.46 (0.11) < 0.001* 0.03 (0.12) 0.82
Q11 Body image 0.23 (0.11) 0.032* 0.03 (0.12) 0.78 0.24 (0.11) 0.03* 0.03 (0.12) 0.77
Q19 Self-esteem 0.46 (0.10) < 0.001* 0.15 (0.11) 0.15 0.46 (0.10) < 0.001* 0.16 (0.11) 0.15
Q26 Negative feelings 0.68 (0.11) < 0.001* 0.76 (0.12) < 0.001* 0.68 (0.11) < 0.001* 0.76 (0.12) <0.001*
Social 1.51 (0.31) < 0.001* 0.46 (0.33) 0.17 1.52 (0.31) < 0.001* 0.45 (0.34) 0.18
Q20 Personal relationship 0.20 (0.09) 0.026* 0.07 (0.10) 0.94 0.20 (0.09) 0.027* 0.01 (0.10) 0.95
Q21 Sexual activity 0.74 (0.10) < 0.001* 0.37 (0.11) 0.001* 0.75 (0.10) < 0.001* 0.36 (0.11) 0.001*
Q22 Social support 0.29 (0.10) 0.003* 0.11 (0.11) 0.30 0.29 (0.10) 0.003* 0.11 (0.11) 0.30
Q27 Being respected 0.28 (0.10) 0.005* 0.02 (0.11) 0.83 0.28 (0.10) 0.004* 0.03 (0.11) 0.81
Environment 0.37 (0.27) 0.18 0.58 (0.30) 0.052 0.38 (0.27) 0.16 0.60 (0.30) 0.04*
Q8 Safety & security 0.20 (0.11) 0.07 0.13 (0.12) 0.28 0.21 (0.11) 0.06 0.14 (0.12) 0.24
Q9 Physical environment 0.02 (0.11) 0.87 0.43 (0.12) < 0.001* 0.02 (0.11) 0.88 0.43 (0.12) <0.001*
Q12 Financial resources 0.31 (0.12) 0.011* 0.09 (0.13) 0.50 0.32 (0.12) 0.008* 0.07 (0.13) 0.62
Q13 Information
acquisition
0.28 (0.11) 0.008* 0.05 (0.11) 0.69 0.28 (0.11) 0.008* 0.04 (0.11) 0.70
Q14 Leisure activities 0.07 (0.11) 0.51 0.46 (0.12) < 0.001* 0.07 (0.11) 0.52 0.47 (0.12) <0.001*
Q23 Home environment 0.05 (0.09) 0.56 0.05 (0.10) 0.59 0.06 (0.09) 0.53 0.06 (0.10) 0.55
Q24 Health service 0.18 (0.10) 0.06 0.28 (0.10) 0.008* 0.17 (0.10) 0.065 0.26 (0.10) 0.011*
Q25 Transportation 0.14 (0.09) 0.12 0.01 (0.10) 0.94 0.15 (0.09) 0.12 0.01 (0.10) 0.92
Q28 Eating 0.12 (0.10) 0.24 0.10 (0.11) 0.33 0.12 (0.10) 0.23 0.11 (0.11) 0.31
* Statistically significant (p < 0.05).
B Z regression coefficient; MMTP Z methadone maintenance treatment program; SE Z standard error; WHOQOL-BREF Z Taiwanese
brief version of World Health Organization’s quality of life.
a Referents were selected from the general population and matched according to age, sex, education, and municipality with MMTP
patients.
b Without any adjustment.
c Adjusted for age, sex, and educational years.
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Table S3 Regression coefficients of model construction for WHOQOL-BREF scores comparing self-paid versus publicly-funded methadone maintenance treatment program
(MMTP) patients.
Domain
Item #
Model 0a Model 1b Model 2c
Self-paid vs. publicly-funded Self-paid vs. publicly-funded Self-paid vs. publicly-funded HIV-positive vs. HIV-negative
B (SE) pd B (SE) pd B (SE) pd B (SE) pd
Physical 0.59 (0.27) 0.03 0.69 (0.27) 0.011* 0.49 (0.30) 0.10 0.53 (0.38) 0.17
Q3: Pain & discomfort 0.02 (0.14) 0.91 0.02 (0.14) 0.88 0.05 (0.16) 0.75 0.10 (0.20) 0.61
Q4: Medication 0.21 (0.14) 0.14 0.20 (0.14) 0.16 0.10 (0.16) 0.54 0.24 (0.20) 0.23
Q10: Energy & fatigue 0.26 (0.12) 0.035 0.28 (0.12) 0.022* 0.14 (0.13) 0.29 0.37 (0.17) 0.033
Q15: Mobility 0.20 (0.12) 0.09 0.21 (0.12) 0.08 0.20 (0.13) 0.13 0.002 (0.17) 0.99
Q16: Sleep & rest 0.26 (0.14) 0.07 0.32 (0.14) 0.025* 0.19 (0.16) 0.22 0.36 (0.20) 0.07
Q17: Activities of daily living 0.17 (0.11) 0.11 0.20 (0.11) 0.08 0.08 (0.12) 0.50 0.33 (0.15) 0.03
Q18: Work capacity 0.30 (0.13) 0.019* 0.34 (0.13) 0.008* 0.24 (0.14) 0.09 0.24 (0.18) 0.19
Psychological 0.99 (0.34) 0.004* 0.96 (0.34) 0.005* 0.50 (0.37) 0.18 1.33 (0.47) 0.006*
Q5: Positive feelings 0.26 (0.14) 0.07 0.26 (0.14) 0.06 0.10 (0.15) 0.53 0.50 (0.19) 0.012*
Q6: Spirit/religion/beliefs 0.25 (0.16) 0.11 0.23 (0.16) 0.14 0.02 (0.17) 0.89 0.59 (0.22) 0.007*
Q7: Think 0.48 (0.14) 0.001* 0.44 (0.14) 0.002* 0.24 (0.15) 0.12 0.60 (0.19) 0.002*
Q11: Body image 0.27 (0.13) 0.046 0.27 (0.14) 0.047 0.23 (0.15) 0.13 0.13 (0.19) 0.51
Q19: Self-esteem 0.31 (0.12) 0.015* 0.33 (0.13) 0.008* 0.22 (0.14) 0.11 0.30 (0.18) 0.09
Q26: Negative feelings 0.08 (0.13) 0.57 0.11 (0.14) 0.44 0.06 (0.15) 0.68 0.13 (0.19) 0.51
Social 1.05 (0.42) 0.012* 1.02 (0.42) 0.017* 0.26 (0.46) 0.57 2.25 (0.58) <0.001*
Q20: Personal relationship 0.19 (0.11) 0.09 0.19 (0.11) 0.10 0.11 (0.13) 0.37 0.25 (0.16) 0.12
Q21: Sexual activity 0.38 (0.14) 0.007* 0.37 (0.14) 0.01* 0.14 (0.16) 0.38 0.70 (0.20) <0.001*
Q22: Social support 0.18 (0.13) 0.16 0.15 (0.13) 0.26 0.03 (0.14) 0.86 0.50 (0.18) 0.007*
Q27: Being respected 0.30 (0.13) 0.019* 0.31 (0.13) 0.02* 0.04 (0.14) 0.80 0.80 (0.18) <0.001*
Environment 0.95 (0.37) 0.01* 0.89 (0.37) 0.017* 0.29 (0.40) 0.48 1.78 (0.51) 0.001*
Q8: Safety & security 0.33 (0.14) 0.015* 0.30 (0.14) 0.033 0.13 (0.15) 0.40 0.55 (0.19) 0.005*
Q9: Physical environment 0.41 (0.13) 0.002* 0.34 (0.13) 0.009* 0.15 (0.14) 0.28 0.51 (0.18) 0.005*
Q12: Financial resources 0.22 (0.14) 0.13 0.24 (0.15) 0.11 0.03 (0.16) 0.84 0.58 (0.20) 0.005*
Q13: Information acquiring 0.24 (0.13) 0.08 0.22 (0.14) 0.11 0.07 (0.15) 0.62 0.45 (0.19) 0.018*
Q14: Leisure activities 0.39 (0.14) 0.006* 0.37 (0.14) 0.01* 0.13 (0.15) 0.40 0.67 (0.20) 0.001*
Q23: Home environment 0.11 (0.11) 0.33 0.07 (0.11) 0.55 0.07 (0.12) 0.57 0.38 (0.16) 0.016*
Q24: Health service 0.10 (0.12) 0.41 0.12 (0.12) 0.30 0.04 (0.13) 0.75 0.25 (0.17) 0.13
Q25: Transportation 0.14 (0.12) 0.24 0.16 (0.12) 0.16 0.04 (0.13) 0.75 0.37 (0.16) 0.023*
Q28: Eating 0.22 (0.12) 0.07 0.20 (0.12) 0.11 0.11 (0.13) 0.41 0.24 (0.17) 0.17
* Statistically significant (p < 0.025).
BZ regression coefficient; HBVZ hepatitis B virus; HCVZ hepatitis C virus; HIVZ human immunodeficiency virus; MMTPZ methadone maintenance treatment program; SEZ standard
error; WHOQOL-BREF Z Taiwanese brief version of the World Health Organization’s quality of life.
a Without any adjusted variable.
b Age, sex, educational years, living status, and fixed employment were adjusted.
c Age, sex, educational years, living status, fixed employment, HIV-positive, HBV-positive, and HCV-positive infections were adjusted.
d Bonferroni adjustment for multiple comparisons was used, and the significant p value was set at 0.025 because we compared healthy
controls versus MMTP patients (Table 2) and publicly-funded MMTP versus self-paid MMTP patients (Table 3).
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QoL and its determinants for heroin addicts 725Appendix 2. Examining the effects of HIV-positive infection without HBV- and HCV-positive
infections.Domain
Item #
Model 2a Model 2b
Self-paid vs.
publicly-funded
HIV-positive vs.
HIV-negative
Self-paid vs.
publicly-funded
HIV-positive vs.
HIV-negative
B (SE) pc B (SE) pc B (SE) pc B (SE) pc
Physical 0.51 (0.28) 0.07 0.37 (0.35) 0.29 0.50 (0.28) 0.08 0.37 (0.36) 0.30
Q3: Pain & discomfort 0.07 (0.15) 0.64 0.11 (0.19) 0.57 0.06 (0.15) 0.68 0.11 (0.19) 0.55
Q4: Medication 0.07 (0.15) 0.62 0.29 (0.19) 0.12 0.05 (0.15) 0.72 0.29 (0.19) 0.12
Q10: Energy & fatigue 0.18 (0.13) 0.15 0.31 (0.16) 0.06 0.17 (0.13) 0.18 0.31 (0.16) 0.057
Q15: Mobility 0.19 (0.12) 0.12 0.03 (0.16) 0.85 0.19 (0.13) 0.77 0.03 (0.16) 0.87
Q16: Sleep & rest 0.21 (0.15) 0.15 0.24 (0.19) 0.20 0.21 (0.15) 0.17 0.23 (0.19) 0.21
Q17: Activities
of daily living
0.07 (0.12) 0.53 0.29 (0.15) 0.049 0.07 (0.12) 0.55 0.28 (0.15) 0.055
Q18: Work capacity 0.19 (0.14) 0.16 0.23 (0.17) 0.19 0.17 (0.14) 0.21 0.23 (0.17) 0.19
Psychological 0.46 (0.35) 0.19 1.23 (0.44) 0.006* 0.45 (0.35) 0.20 1.23 (0.44) 0.006*
Q5: Positive feelings 0.14 (0.15) 0.35 0.46 (0.18) 0.012* 0.15 (0.15) 0.32 0.46 (0.18) 0.013*
Q6: Spirit/religion/beliefs 0.06 (0.16) 0.73 0.51 (0.20) 0.013* 0.05 (0.16) 0.78 0.52 (0.21) 0.013*
Q7: Think 0.24 (0.14) 0.09 0.60 (0.18) 0.001* 0.24 (0.14) 0.09 0.60 (0.18) 0.001*
Q11: Body image 0.18 (0.14) 0.22 0.16 (0.18) 0.39 0.18 (0.14) 0.22 0.16 (0.18) 0.38
Q19: Self-esteem 0.19 (0.13) 0.15 0.31 (0.16) 0.059 0.18 (0.13) 0.17 0.32 (0.17) 0.055
Q26: Negative feelings 0.10 (0.14) 0.48 0.19 (0.18) 0.30 0.11 (0.14) 0.45 0.20 (0.18) 0.27
Social 0.13 (0.43) 0.77 1.90 (0.55) 0.001* 0.14 (0.44) 0.76 1.93 (0.55) 0.001*
Q20: Personal relationship 0.07 (0.12) 0.57 0.20 (0.15) 0.19 0.07 (0.12) 0.54 0.20 (0.15) 0.20
Q21: Sexual activity 0.11 (0.15) 0.47 0.65 (0.19) 0.001* 0.10 (0.15) 0.49 0.66 (0.19) 0.001*
Q22: Social support 0.08 (0.14) 0.57 0.42 (0.17) 0.017* 0.08 (0.14) 0.58 0.43 (0.18) 0.015*
Q27: Being respected 0.02 (0.13) 0.89 0.63 (0.17) < 0.001* 0.02 (0.13) 0.87 0.64 (0.17) <0.001*
Environment 0.42 (0.38) 0.28* 1.47 (0.48) 0.003* 0.42 (0.39) 0.27 1.48 (0.49) 0.003*
Q8: Safety & security 0.16 (0.15) 0.28 0.45 (0.19) 0.017* 0.18 (0.15) 0.22 0.46 (0.19) 0.015*
Q9: Physical environment 0.20 (0.13) 0.14 0.40 (0.17) 0.017* 0.18 (0.13) 0.17 0.40 (0.17) 0.02*
Q12: Financial resources 0.13 (0.16) 0.41 0.43 (0.20) 0.028 0.12 (0.16) 0.43 0.44 (0.20) 0.027
Q13: Information acquiring 0.11 (0.14) 0.46 0.44 (0.18) 0.016* 0.12 (0.14) 0.41 0.43 (0.18) 0.018*
Q14: Leisure activities 0.20 (0.15) 0.16 0.58 (0.18) 0.002* 0.20 (0.15) 0.18 0.59 (0.18) 0.001*
Q23: Home environment 0.02 (0.12) 0.90 0.29 (0.15) 0.047 0.02 (0.12) 0.89 0.29 (0.15) 0.051
Q24: Health service 0.02 (0.13) 0.89 0.19 (0.16) 0.23 0.02 (0.13) 0.85 0.19 (0.16) 0.25
Q25: Transportation 0.07 (0.12) 0.55 0.33 (0.15) 0.031 0.07 (0.12) 0.73 0.33 (0.15) 0.03
Q28: Eating 0.08 (0.13) 0.56 0.19 (0.16) 0.24 0.07 (0.13) 0.59 0.20 (0.16) 0.22
* Statistically significant (p < 0.025).
BZ regression coefficient; HBVZ hepatitis B virus; HCVZ hepatitis C virus; HIVZ human immunodeficiency virus; MMTPZmethadone
maintenance treatment program; SE Z standard error; WHOQOL-BREF Z Taiwanese brief version of the World Health Organization’s
quality of life.
a Age, sex, educational years, living status, fixed employment, and HIV-positive infection were adjusted.
b Age, sex, educational years, living status, fixed employment, HIV-positive, HBV-positive, and HCV-positive infections were adjusted.
c Bonferroni adjustment for multiple comparisons was used, and the significant p value was set at 0.025 because we compared healthy
controls versus MMTP patients (Table 2) and publicly-funded MMTP versus self-paid MMTP patients (Table 3).
726 C.-Y. Lin et al.Appendix 3. Comparing WHOQOL-BREF
domains with those of Lin et al25 and Yen
et al26.Study Heroin user Healthy control Cohen’s
dDomain Mean SD Mean SD
Lin et al25 (n Z 121) (n Z 157)
Physical 12.51 1.86 13.57 1.82 0.57
Psychological 12.18 2.01 13.07 1.96 0.45
Social 12.59 2.78 13.80 2.02 0.51
Environment 12.71 2.24 14.08 2.08 0.64
Yen et al26 (n Z 123) (n Z 106)
Physical 12.48 2.42 15.28 1.90 1.28
Psychological 11.50 2.69 12.66 1.97 0.49
Social 12.21 2.53 13.87 2.14 0.71
Environment 11.92 2.11 12.26 2.58 0.14
Current study
Publicly-funded
(n Z 129) (n Z 113)
Physical 11.93 1.86 15.01 1.93 1.12
Psychological 12.01 2.66 13.51 2.34 0.41
Social 12.73 3.13 13.95 1.98 0.31
Environment 12.47 2.80 12.86 1.88 0.12
Current study
Self-paid
(n Z 105) (n Z 104)
Physical 12.53 1.90 15.44 2.15 1.07
Psychological 12.88 2.07 13.58 2.44 0.24
Social 13.50 2.76 14.03 2.34 0.15
Environment 13.48 2.24 12.88 2.18 0.20
Cohen’s d Z mean difference divided by pooled SD;
SD Z standard deviation; WHOQOL-BREF Z Taiwanese brief
version of the World Health Organization’s quality of life.References
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